Shopping Cart 0
Cart Subtotal
USD 0

MilliporeSigma - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

MilliporeSigma, formerly Sigma-Aldrich Corp, a subsidiary of Merck KGaA is a life sciences and technology company which offers biochemical and organic chemical products, kits and services. Its products and services find application in scientific research including genomic and proteomic research; diagnosis of diseases; pharmaceutical development and biotechnology sectors. The company offers its solutions to hospitals, biotechnology and pharmaceutical companies, commercial laboratories, universities, industrial companies, governmental institutions, non-profit organizations, diagnostic, and chemical and electronics companies. It operates across the Americas, Asia-Pacific, Europe, the Middle East and Africa. MilliporeSigma is headquartered in St. Louis, Missouri, the US.

MilliporeSigma-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

MilliporeSigma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10

MilliporeSigma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

MilliporeSigma, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

MilliporeSigma to Enter into Agreement with Samsung Biologics 13

MilliporeSigma Enters into Agreement with Angiex 14

F. Hoffmann-La Roche Expands its Distribution Agreement with MilliporeSigma 15

Sigma-Aldrich Enters into Agreement with Sanger Institute 16

Sigma-Aldrich Enters into Distribution Agreement with IROA Technologies 17

Sigma-Aldrich Enters into Distribution Agreement with Roche 18

BioSilta Enters into Co-Marketing Agreement with Sigma-Aldrich 19

Sigma-Aldrich Enters Into Distribution Agreement With Paragon Scientific 20

Sigma Life Science Enters Into Distribution Agreement With The Culture Collections of Public Health England 21

AB Sciex Enters Into Distribution Agreement With Sigma-Aldrich For Sciex Ichemistry Solutions 22

Sigma Life Science Expands Agreement With Autism Speaks To Develop Rat Models For Autism Research 23

Sigma Life Science Enters Into Co-Marketing Agreement With Axiogenesis 24

Genovis Enters Into Distribution Agreement With Sigma-Aldrich 25

TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 26

Licensing Agreements 27

Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 27

Sage Labs Enters Into Licensing Agreement With Caribou Biosciences 28

Sigma-Aldrich Enters Into Licensing Agreement With Horizon Discovery For CompoZr Zinc Finger Nuclease Technology 29

Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 30

Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 31

Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 32

Materia Extends Licensing Agreement With Sigma Aldrich 33

Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 34

Sigma Life Science Enters Into Licensing Agreement With Kyoto University 35

Asset Transactions 36

Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 36

Acquisition 38

Merck Acquires Sigma-Aldrich for USD17 Billion 38

Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 40

Sigma-Aldrich Acquires Research Organics, Manufacturer Of Biochemicals 41

MilliporeSigma-Key Competitors 42

MilliporeSigma-Key Employees 43

MilliporeSigma-Locations And Subsidiaries 44

Head Office 44

Other Locations & Subsidiaries 44

Joint Venture 44

Recent Developments 45

Strategy And Business Planning 45

Oct 11, 2017: MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration 45

Sep 21, 2017: MilliporeSigma Opens Chinas First BioReliance End-to-End Biodevelopment Center in Shanghai 47

May 12, 2017: MilliporeSigma and Stelis Biopharma Open First Joint Bioprocess Scale-up Lab in India 48

Jan 10, 2017: MilliporeSigma Expands End-to-End Biodevelopment Centers in North America, China and Europe 49

Product News 50

May 17, 2017: MilliporeSigma Develops Alternative CRISPR Genome Editing Method 50

May 16, 2017: MilliporeSigma's CHOZN Expression System Selected for Bi-specific Antibody Development by SystImmune 51

May 01, 2017: MilliporeSigma's Mobius 2,000-liter Single-use Bioreactors to Expand Avid Bioservices' Manufacturing Capabilities 52

Feb 13, 2018: Merck Launches Viresolve Barrier Capsule Filters to Protect Against Bioreactor Contamination 53

Other Significant Developments 54

Oct 08, 2018: MilliporeSigma's novel chemiflex raw materials program solves regulatory compliance challenges in small molecule drug manufacturing 54

Sep 25, 2017: Avid Bioservices Expands Manufacturing Capabilities With Installation and Validation of Two MilliporeSigma Mobius 2,000-Liter Single-Use Bioreactors in Its Myford Facility 55

Appendix 56

Methodology 56

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Figures

MilliporeSigma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

MilliporeSigma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

MilliporeSigma, Pharmaceuticals & Healthcare, Key Facts 2

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

MilliporeSigma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

MilliporeSigma, Deals By Therapy Area, 2012 to YTD 2018 9

MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10

MilliporeSigma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

MilliporeSigma to Enter into Agreement with Samsung Biologics 13

MilliporeSigma Enters into Agreement with Angiex 14

F. Hoffmann-La Roche Expands its Distribution Agreement with MilliporeSigma 15

Sigma-Aldrich Enters into Agreement with Sanger Institute 16

Sigma-Aldrich Enters into Distribution Agreement with IROA Technologies 17

Sigma-Aldrich Enters into Distribution Agreement with Roche 18

BioSilta Enters into Co-Marketing Agreement with Sigma-Aldrich 19

Sigma-Aldrich Enters Into Distribution Agreement With Paragon Scientific 20

Sigma Life Science Enters Into Distribution Agreement With The Culture Collections of Public Health England 21

AB Sciex Enters Into Distribution Agreement With Sigma-Aldrich For Sciex Ichemistry Solutions 22

Sigma Life Science Expands Agreement With Autism Speaks To Develop Rat Models For Autism Research 23

Sigma Life Science Enters Into Co-Marketing Agreement With Axiogenesis 24

Genovis Enters Into Distribution Agreement With Sigma-Aldrich 25

TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 26

Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 27

Sage Labs Enters Into Licensing Agreement With Caribou Biosciences 28

Sigma-Aldrich Enters Into Licensing Agreement With Horizon Discovery For CompoZr Zinc Finger Nuclease Technology 29

Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 30

Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 31

Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 32

Materia Extends Licensing Agreement With Sigma Aldrich 33

Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 34

Sigma Life Science Enters Into Licensing Agreement With Kyoto University 35

Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 36

Merck Acquires Sigma-Aldrich for USD17 Billion 38

Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 40

Sigma-Aldrich Acquires Research Organics, Manufacturer Of Biochemicals 41

MilliporeSigma, Key Competitors 42

MilliporeSigma, Key Employees 43

MilliporeSigma, Subsidiaries 44

MilliporeSigma, Joint Venture 44

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

MilliporeSigma, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

MilliporeSigma, formerly Sigma-Aldrich Corp, a subsidiary of Merck KGaA is a life sciences and technology company which offers biochemical and organic chemical products, kits and services. Its products and services find application in scientific research including genomic and proteomic research; diagnosis of diseases; pharmaceutical development and biotechnology sectors. The company offers its solutions to hospitals, biotechnology and pharmaceutical companies, commercial laboratories, universities, industrial companies, governmental institutions, non-profit organizations, diagnostic, and chemical and electronics companies. It operates across the Americas, Asia-Pacific, Europe, the Middle East and Africa. MilliporeSigma is headquartered in St. Louis, Missouri, the US.

MilliporeSigma-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

MilliporeSigma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10

MilliporeSigma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

MilliporeSigma, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

MilliporeSigma to Enter into Agreement with Samsung Biologics 13

MilliporeSigma Enters into Agreement with Angiex 14

F. Hoffmann-La Roche Expands its Distribution Agreement with MilliporeSigma 15

Sigma-Aldrich Enters into Agreement with Sanger Institute 16

Sigma-Aldrich Enters into Distribution Agreement with IROA Technologies 17

Sigma-Aldrich Enters into Distribution Agreement with Roche 18

BioSilta Enters into Co-Marketing Agreement with Sigma-Aldrich 19

Sigma-Aldrich Enters Into Distribution Agreement With Paragon Scientific 20

Sigma Life Science Enters Into Distribution Agreement With The Culture Collections of Public Health England 21

AB Sciex Enters Into Distribution Agreement With Sigma-Aldrich For Sciex Ichemistry Solutions 22

Sigma Life Science Expands Agreement With Autism Speaks To Develop Rat Models For Autism Research 23

Sigma Life Science Enters Into Co-Marketing Agreement With Axiogenesis 24

Genovis Enters Into Distribution Agreement With Sigma-Aldrich 25

TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 26

Licensing Agreements 27

Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 27

Sage Labs Enters Into Licensing Agreement With Caribou Biosciences 28

Sigma-Aldrich Enters Into Licensing Agreement With Horizon Discovery For CompoZr Zinc Finger Nuclease Technology 29

Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 30

Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 31

Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 32

Materia Extends Licensing Agreement With Sigma Aldrich 33

Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 34

Sigma Life Science Enters Into Licensing Agreement With Kyoto University 35

Asset Transactions 36

Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 36

Acquisition 38

Merck Acquires Sigma-Aldrich for USD17 Billion 38

Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 40

Sigma-Aldrich Acquires Research Organics, Manufacturer Of Biochemicals 41

MilliporeSigma-Key Competitors 42

MilliporeSigma-Key Employees 43

MilliporeSigma-Locations And Subsidiaries 44

Head Office 44

Other Locations & Subsidiaries 44

Joint Venture 44

Recent Developments 45

Strategy And Business Planning 45

Oct 11, 2017: MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration 45

Sep 21, 2017: MilliporeSigma Opens Chinas First BioReliance End-to-End Biodevelopment Center in Shanghai 47

May 12, 2017: MilliporeSigma and Stelis Biopharma Open First Joint Bioprocess Scale-up Lab in India 48

Jan 10, 2017: MilliporeSigma Expands End-to-End Biodevelopment Centers in North America, China and Europe 49

Product News 50

May 17, 2017: MilliporeSigma Develops Alternative CRISPR Genome Editing Method 50

May 16, 2017: MilliporeSigma's CHOZN Expression System Selected for Bi-specific Antibody Development by SystImmune 51

May 01, 2017: MilliporeSigma's Mobius 2,000-liter Single-use Bioreactors to Expand Avid Bioservices' Manufacturing Capabilities 52

Feb 13, 2018: Merck Launches Viresolve Barrier Capsule Filters to Protect Against Bioreactor Contamination 53

Other Significant Developments 54

Oct 08, 2018: MilliporeSigma's novel chemiflex raw materials program solves regulatory compliance challenges in small molecule drug manufacturing 54

Sep 25, 2017: Avid Bioservices Expands Manufacturing Capabilities With Installation and Validation of Two MilliporeSigma Mobius 2,000-Liter Single-Use Bioreactors in Its Myford Facility 55

Appendix 56

Methodology 56

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Figures

MilliporeSigma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

MilliporeSigma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

MilliporeSigma, Pharmaceuticals & Healthcare, Key Facts 2

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

MilliporeSigma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

MilliporeSigma, Deals By Therapy Area, 2012 to YTD 2018 9

MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10

MilliporeSigma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

MilliporeSigma to Enter into Agreement with Samsung Biologics 13

MilliporeSigma Enters into Agreement with Angiex 14

F. Hoffmann-La Roche Expands its Distribution Agreement with MilliporeSigma 15

Sigma-Aldrich Enters into Agreement with Sanger Institute 16

Sigma-Aldrich Enters into Distribution Agreement with IROA Technologies 17

Sigma-Aldrich Enters into Distribution Agreement with Roche 18

BioSilta Enters into Co-Marketing Agreement with Sigma-Aldrich 19

Sigma-Aldrich Enters Into Distribution Agreement With Paragon Scientific 20

Sigma Life Science Enters Into Distribution Agreement With The Culture Collections of Public Health England 21

AB Sciex Enters Into Distribution Agreement With Sigma-Aldrich For Sciex Ichemistry Solutions 22

Sigma Life Science Expands Agreement With Autism Speaks To Develop Rat Models For Autism Research 23

Sigma Life Science Enters Into Co-Marketing Agreement With Axiogenesis 24

Genovis Enters Into Distribution Agreement With Sigma-Aldrich 25

TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 26

Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 27

Sage Labs Enters Into Licensing Agreement With Caribou Biosciences 28

Sigma-Aldrich Enters Into Licensing Agreement With Horizon Discovery For CompoZr Zinc Finger Nuclease Technology 29

Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 30

Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 31

Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 32

Materia Extends Licensing Agreement With Sigma Aldrich 33

Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 34

Sigma Life Science Enters Into Licensing Agreement With Kyoto University 35

Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 36

Merck Acquires Sigma-Aldrich for USD17 Billion 38

Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 40

Sigma-Aldrich Acquires Research Organics, Manufacturer Of Biochemicals 41

MilliporeSigma, Key Competitors 42

MilliporeSigma, Key Employees 43

MilliporeSigma, Subsidiaries 44

MilliporeSigma, Joint Venture 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

MilliporeSigma, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.